Infors USA Inc.

Infors USA Inc., a for-profit manufacturer of specialized laboratory incubation and bioprocess equipment headquartered in Annapolis Junction, Maryland, operates as a prime contractor delivering shaking incubators, fermentation monitoring systems, and related accessories to federal research agencies under individual purchase orders—98% of its federal footprint consists of prime awards, with the remaining 2% routed through subcontract vehicles. The vendor competes predominantly full-and-open across its portfolio, with recurrent total small business set-asides appearing on roughly one-third of recent awards; it registered for federal contracting in June 2014 and has sustained activity across the past decade with 116 total prime and sub awards.

Infors USA's customer concentration is extreme and deliberate. The National Institute of Allergy and Infectious Diseases accounts for 36 awards and $2.1 million in combined potential value—representing 31% of all awards and 45% of all potential value across the vendor's portfolio. The next four NIH institutes—the National Cancer Institute (15 awards, $214 thousand), the National Heart Lung and Blood Institute (11 awards, $264 thousand), the National Institute of Environmental Health Sciences (10 awards, $469 thousand), and the National Institute of Child Health and Human Development (7 awards, $202 thousand)—account for an additional 43 awards and $1.1 million combined. Together, these five NIH institutes represent 79 of the vendor's 116 awards (68% coverage) and $3.2 million of its $4.7 million combined potential value (69% coverage). Non-NIH federal customers include the Department of Agriculture's Agricultural Research Service, the Department of Veterans Affairs, the Army Research Laboratory, the National Institute of Standards and Technology, and the FDA—each placing between one and three orders over the source window. The vendor's actual obligated spending ($5.1 million) has exceeded its combined potential value ($4.7 million) by 8%, indicating that some awards have been exercised or extended beyond their ceiling values.

Capability scope is tightly bounded by NAICS 334516 (Analytical Laboratory Instrument Manufacturing), which covers 105 of the vendor's 116 awards. The vendor manufactures Infors-HT branded incubation shakers (Minitron, Multitron, and Triple Multitron product lines), fermentation monitoring equipment compatible with existing chemostat systems, CO2-gassing and humidity control modules, and associated accessories. Representative prime work includes a $193,047 NIAID order for HT Multitron and Minitron incubator shakers (awarded August 2024, ultimate completion August 2025), a $169,060 National Institute of Environmental Health Sciences order for Infors Multitron laboratory incubation shakers (awarded September 2023, completed January 2024), a $166,619 Department of Agriculture Agricultural Research Service order for a microbial chemostat (awarded September 2023, completed February 2024), an $83,825 total small business set-aside order from USDA's Agricultural Research Service for a stackable shaker/incubator with UV sterilization capabilities (awarded March 2026, due June 2026), and a $96,200 NIH order for two Triple Multitron Standard Incubation Shakers with Top Cooling (awarded June 2026, due June 2027). The vendor also performs maintenance and repair work; recent subcontract awards include a November 2025 service maintenance agreement for shaking incubators placed through Roberts Oxygen Co Inc. for the NIAID Vaccine Research Center, and an April 2025 capital equipment order flowing through IT1 Source LLC, also for the NIAID VRC.

Activity has been flat to declining over the most recent five-year window. The vendor achieved ten awards in 2022 and ten in 2023, eleven in 2024, but only five in 2025 and three in the first half of 2026—suggesting either a procurement slowdown at NIH or a shift in purchasing patterns away from individual purchase orders toward longer-term agreements or alternative acquisition vehicles. Only two awards carry ultimate completion dates within the next twenty-four months, with combined potential value of $118 thousand—a minimal recompete exposure relative to the vendor's historical run rate. The vendor does not hold seats on government-wide IDIQs or multi-award GWACs; its largest parent vehicles are a Blanket Purchase Agreement (75N98024A00180) and a Chief Information Officer Commodities and Solutions arrangement, each carrying only a single task order.